Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Staff at the Nuffield Division of Anaesthetics have helped the Acute Vascular Imaging Centre to reach a major landmark that could boost care for stroke patients.

Dr Matt Rowland and Dr Kyle Pattinson were part of a team who, for the first time, used state-of-the-art MRI technology to scan a critically ill patient in order to find out how blood flow in the brain is affected by a subarachnoid haemorrhage. 

The scanning was carried out at the Acute Vascular Imaging Centre (AVIC), part of the Radcliffe Department of Medicine at the John Radcliffe Hospital.

Matt Rowland said: 'The opportunity to scan these patients will allow us to look for new ways to improve treatment'.

Similar stories

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Success for NDCN teams at the Vice-Chancellor's Awards 2026

The Vice-Chancellor’s Awards, which recognise achievements and celebrate success across the collegiate University, were announced at a special ceremony hosted by the VC at the Schwarzman’s Sohmen Concert Hall on Thursday 4 June

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.